{"denoms":[{"counts":[{"groupId":"BG000","value":"196"},{"groupId":"BG001","value":"195"},{"groupId":"BG002","value":"391"}],"units":"Participants"}],"groups":[{"description":"An anti-CD20 monoclonal antibody\n\nofatumumab: The ofatumumab (IV) dosage and schedule is 12 doses administered over 24 weeks or until disease progression, unacceptable toxicity.\n\nWeek 1: 300 mg initial dose Week 2 through 8: 2,000 mg (once weekly) Week 12, 16, 20 and 24: 2,000 mg (every 4 weeks)","id":"BG000","title":"Ofatumumab (Arm A)"},{"description":"A Bruton Tyrosine Kinase Inhibitor\n\nibrutinib: ibrutinib 420 mg (3 x 140-mg capsules) will be administered orally once daily until disease progression or unacceptable toxicity","id":"BG001","title":"Ibrutinib (Arm B)"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"<=18 years"},{"measurements":[{"groupId":"BG000","value":"75"},{"groupId":"BG001","value":"77"},{"groupId":"BG002","value":"152"}],"title":"Between 18 and 65 years"},{"measurements":[{"groupId":"BG000","value":"121"},{"groupId":"BG001","value":"118"},{"groupId":"BG002","value":"239"}],"title":">=65 years"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Age, Categorical","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"8.88","value":"66.8"},{"groupId":"BG001","spread":"10.15","value":"66.1"},{"groupId":"BG002","spread":"9.53","value":"66.5"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"59"},{"groupId":"BG001","value":"66"},{"groupId":"BG002","value":"125"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"137"},{"groupId":"BG001","value":"129"},{"groupId":"BG002","value":"266"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"}]}